Search results
Significant Benefit With Liver Transplantation in ACLF
Medscape· 16 hours agoTo date, the results show that 3-month post–liver transplantation mortality rates in patients with...
Edible Carbon Beads Can Reduce Cirrhosis Liver Disease By Restoring Gut Microbiome
GoodNewsNetwork· 4 days agoInnovative carbon beads, invented by researchers at University College London, reduce bad bacteria...
She's been waiting for a liver donation for over a year: 'I know God has a plan for me, but its...
CBS 6 Richmond· 6 days agoMother and wife Tina Doane was diagnosed with Stage 4 cirrhosis of the liver and given two years to live if she didn't receive a liver ...
Lipocine Presents 52 Week Results from LPCN 1148 Phase 2 Study in Late Breaking Session at EASL...
The Herald Journal· 3 days agoLipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company, today announced that Phase 2 results on LPCN 1148 in cirrhosis were featured in a late breaking oral presentation ...
Seladelpar Shows Clinically Meaningful Improvements in PBC
Medscape· 3 days agoSeladelpar, an investigational selective peroxisome proliferator-activated receptor delta agonist, achieves both biochemical and clinically meaningful improvements in pruritus and liver injury ...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 5 days agoA late-breaking oral presentation will feature 96-week data from HARMONY, a Phase 2b study evaluating the efficacy and safety of EFX in patients with metabolic dysfunction-associated steatohepatitis ...
Surrozen reports positive Phase 1a trial results for liver therapy By Investing.com
Investing.com· 3 days agoThe study, which involved healthy volunteers and patients with a history of liver cirrhosis, was...
Boehringer Ingelheim's survodutide shows breakthrough improvement in liver fibrosis with no...
Benzinga· 7 days agoNews builds on previously announced primary endpoint, which showed up to 83.0% of adults achieved statistically significant improvement in metabolic dysfunction-associated steatohepatitis (MASH) versus placebo
'Dramatic' Phase 2 Results for Survodutide in MASH, Fibrosis
Medscape· 2 days agoSurvodutide, a dual agonist that targets glucagon and glucagon-like peptide 1 receptors, led to a...
Baytown worship pastor encourages others while battling medical problems
FOX 26 Houston· 1 day agoA local bilingual worship pastor is encouraging others who are facing health and life challenges...
